Jessica Robb is a Neurology physician affiliated with University of Rochester. OpenAlex indexes 8 publications with 233 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
42.4%Serotonin-1b and Serotonin-1d Receptor Agonist12.5%Sumatriptan Succinate60%Rizatriptan40%Part D<11 patientsInfluenza A M2 Protein Inhibitor6.2%Amantadine100%Part D<11 patients+ 5 more classes in this area
Musculoskeletal
40.8%gamma-Aminobutyric Acid-ergic Agonist30.5%Baclofen100%Part D≥33 patientsCentral alpha-2 Adrenergic Agonist6.5%Tizanidine Hcl100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
12.8%Other immunosuppressants4.7%Dimethyl Fumarate100%Part D<11 patientsOther immunostimulants4.7%Glatiramer Acetate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Teleconsultation will replace most face-to-face interactions in the multiple sclerosis clinic – Yes
Multiple Sclerosis Journal
2020 - Comparison of telemedicine versus in-person visits for persons with multiple sclerosis: A randomized crossover study of feasibility, cost, and satisfaction
Multiple Sclerosis and Related Disorders
2019 - Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium
Multiple Sclerosis Journal
2018
Similar KOLs
Other experts from the same institution or the same specialty.
David Bushinsky, MD
University of Rochester
Mark Taubman, MD
University of Rochester
Richard Sterns, MD
University of Rochester
Hochang Lee, MD
University of Rochester
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”